Drug intelligence / Profile preview

spleen aminopeptide

Development stage
Unknown
Lead developer
Zhejiang Fengan Biopharmaceutical
Modality
Peptides
Administration
Oral
01

Overview

Spleen aminopeptide oral lyophilized powder is a biological immunomodulator developed by Zhejiang Fengan Biopharmaceutical, marketed under brand names such as FuKetuo and Lifushu. It is a polypeptide extract derived from healthy animal spleens, containing a complex mixture of low-molecular-weight peptides and amino acids. The drug functions by regulating cellular immune function, specifically by promoting the maturation, differentiation, and activation of T-lymphocytes, and enhancing the phagocytic and cytotoxic activities of macrophages and natural killer (NK) cells. In China, it is approved for the treatment of recurrent respiratory infections, chronic bronchitis, and asthma, as well as for supportive care in cancer patients undergoing chemotherapy or radiotherapy to mitigate treatment-induced immune suppression. It is also utilized in the management of autoimmune diseases and viral infections such as severe herpes zoster.

Brand names
FuKetuoLifushu复可托利福舒
Other names
Spleen aminopeptide oral lyophilized powder脾氨肽口服冻干粉

Beyond the preview

Go deeper on spleen aminopeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on spleen aminopeptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call